Domingo Cesar Balderramo
机构：Hospital Privado · ORCID：0000-0001-9598-2577
发表论文 156 篇 · 总被引 2337 次 · h-index 25
代表论文
- Global evolution of inflammatory bowel disease across epidemiologic stages (2025 · Nature · 被引 437)
- Risankizumab for Ulcerative Colitis (2024 · JAMA · 被引 125)
- Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies (2024 · The Lancet · 被引 100)
- Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial (2026 · The Lancet. Gastroenterology & hepatology · 被引 8)
- Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes (2024 · The Lancet Regional Health - Americas · 被引 4)
- Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research Network (2026 · Annals of Hepatology · 被引 2)